Professor, Department of Neurological Sciences

Neurology

Dr. Matthew N. Meriggioli practices Neurology. Matthew Meriggioli is a published physician as well. He has 46 publications published. The latest was: Circulating levels of IGF-I in patients with chronic uremia on conservative dietary treatment.

Publications

---

• Editorial by concerned physicians: Unintended effect of the orphan drug act on the potential cost of 3,4-diaminopyridine.
• Current Treatment, Emerging Translational Therapies, and New Therapeutic Targets for Autoimmune Myasthenia Gravis.
• Recombinant IgG2a Fc (M045) multimers effectively suppress experimental autoimmune Myasthenia gravis.
• Introduction for Myasthenia Gravis and Related Disorders.
• Noninvasive ventilation allows gastrostomy tube placement in patients with advanced ALS.
• Myasthenia gravis.
• Monomelic amyotrophy with late progression.
• Treatment of Myasthenia gravis with mycophenolate mofetil: a case report.
• Electrodiagnostic significance of supramaximally stimulated A-waves.
• Chronic inflammatory demyelinating polyneuropathy after treatment with interferon-alpha.
• Distinguishing clinical and electrodiagnostic features of X-linked bulboSpinal neuronopathy.
• Prominent Inflammatory changes on muscle biopsy in patients with Miyoshi myopathy.
• Complex repetitive Discharges: cause or effect of neurogenic muscle hypertrophy?
• Peripheral neuropathy and connective tissue Disease. Watch for this twosome when hunting for a diagnosis.
• Conduction block and continuous motor unit activity in Chronic acquired demyelinating polyneuropathy.
• Mycophenolate mofetil for Myasthenia gravis: an analysis of efficacy, safety, and tolerability.
• Mycophenolate mofetil in dermatomyositis: is it safe?
• HMG-CoA Reductase Inhibitor Myopathy: Clinical, Electrophysiological, and Pathologic Data in Five Patients.
• Etanercept treatment in corticosteroid-dependent Myasthenia gravis.
• Myasthenia gravis: diagnosis.
• Single fiber EMG as an outcome measure in Myasthenia gravis: results from a double-blind, placebo-controlled trial.
• GM-CSF-induced regulatory T cells selectively inhibit anti-acetylcholine receptor-specific immune responses in experimental Myasthenia gravis.
• Novel and recurrent EMD mutations in patients with Emery-Dreifuss Muscular dystrophy, identify exon 2 as a mutation hot spot.
• Novel LMNA mutations in patients with Emery-Dreifuss Muscular dystrophy and functional characterization of four LMNA mutations.
• In vivo adsorption of autoantibodies in myasthenia gravis using NanoDisc-incorporated acetylcholine receptor.
• Hashimoto encephalopathy with fulminant myocarditis.
• NanoDisc-incorporated hemagglutinin provides protective immunity against influenza virus infection.
• Acetylcholine receptor-alpha subunit expression in Myasthenia gravis: a role for the autoantigen in pathogenesis?
• Autoimmune Myasthenia gravis: emerging clinical and biological heterogeneity.
• Myasthenia gravis with anti-acetylcholine receptor antibodies.
• Regulation of apoptosis and caspase-8 expression in neuroblastoma cells by isoforms of the IG20 gene.
• Strategies for treating autoimmunity: novel insights from experimental Myasthenia gravis.
• Regulatory T cells induced by GM-CSF suppress ongoing experimental Myasthenia gravis.
• IVIG in Myasthenia gravis: getting enough "bang for the buck".
• Suppression of experimental autoimmune Myasthenia gravis by granulocyte-macrophage colony-stimulating factor is associated with an expansion of FoxP3+ regulatory T cells.
• Late appearance of dropped head syndrome after radiotherapy for Hodgkin's Disease.
• Predictive value of serum anti-C1q antibody levels in experimental autoimmune Myasthenia gravis.
• Use of immunoassays in neurological diagnosis and research.
• Advances in the diagnosis of neuromuscular junction Disorders.
• Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment.
• [Can the treatment with L-carnitine improve the inflammation in Chronic hemodialysis patients?].
• Mycophenolate mofetil for Myasthenia gravis: a double-blind, placebo-controlled pilot study.
• Fatigue and abnormal neuromuscular transmission in Kennedy's Disease.
• Clinical immunopharmacology of autoimmune neuropathies and myopathies.
• Circulating levels of IGF-I in patients with Chronic uremia on conservative dietary treatment.

Schools

---

• R Franklin Univ Of Med amp Sci

• Loyola University Med Center

• Northwestern Mem Hospital

Procedures Preformed

---

• EEG (Electroencephalogram)
• EMG (Electromyography)

Conditions Treated

---

• Anterior Horn Disease
• Ataxia
• Autonomic Disorders
• Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
• View All

Doctors Specialties

---

• Clinical Neurophysiology
• Neurology

Accepted Insurances

---

Education

---

• Loyola University
• McGaw Medical Center of Northwestern University
• Rosalind Franklin University of Medicine and Science

Hospital

---

• Rush University Medical Center
• University of Illinois Hospital & Health Sciences System

Helpful Reviews

---

Give Anonymous Review

Similar Doctors

---

	Dr. Mary L. Tomyanovich, MD This Doctor is OpenDoctor Recommended.
	Dr. Julie Rowin, MD This Doctor is OpenDoctor Recommended.
	Dr. Mark J. Alberts, MD This Doctor is OpenDoctor Recommended.
	Dr. Srishti Nangia, MD This Doctor is OpenDoctor Recommended.
	Dr. Teepu Siddique, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Sayona John, MD This Doctor is OpenDoctor Recommended.
	Dr. Lawrence P. Scibilia, MD This Doctor is OpenDoctor Recommended.
	Dr. Rebecca M. Garcia Sosa, MD
	Dr. Jay A. Gottfried, MD This Doctor is OpenDoctor Recommended.
	Dr. Michael G. Gibbs, MD
	Dr. Tania J. Rebeiz, MD This Doctor is OpenDoctor Recommended.
	Dr. Pedro W. Vivar Cruz, MD This Doctor is OpenDoctor Recommended.
	Dr. Ruby Upadhyay, MD
	Arash H. Niktarash
	Dr. Sohail S. Ahmed, MD

---

Doctor Directory | TOS | twitter | FB | Angel | blog